Kairos Pharma Ltd KAPA Q1 2026 Earnings EPS Misses Estimates as PreRevenue Stage Continues NMRA Q1 2026 Earnings NarrowerthanExpected Loss Reflects Operational Discipline SkyWater Technology Q1 2026 Earnings EPS Misses Estimates Stock Holds Gains NTLA Q1 2026 Earnings NarrowerThanExpected Loss Fuels Optimism in Gene Editing Pipeline PRF Technologies PRFX Q2 2024 Earnings Deep EPS Miss as Operating Losses Widen Centene Q1 2026 Earnings EPS Surges 56 Above Estimates as Managed Care Segment Shows Strength